315 related articles for article (PubMed ID: 17216635)
1. Structure-activity relationship of HP (2-20) analog peptide: enhanced antimicrobial activity by N-terminal random coil region deletion.
Park Y; Park SC; Park HK; Shin SY; Kim Y; Hahm KS
Biopolymers; 2007; 88(2):199-207. PubMed ID: 17216635
[TBL] [Abstract][Full Text] [Related]
2. Effects of N- and C-terminal truncation of HP (2-20) from Helicobacter pylori ribosomal protein L1 (RPL1) on its anti-microbial activity.
Park Y; Hahm KS
Biotechnol Lett; 2005 Feb; 27(3):193-9. PubMed ID: 15717129
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial synergism of novel antibiotic peptides with chloramphenicol.
Park Y; Kim HJ; Hahm KS
Biochem Biophys Res Commun; 2004 Aug; 321(1):109-15. PubMed ID: 15358222
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
5. HP (2-20) derived from the amino terminal region of helicobacterpylori ribosomal protein L1 exerts its antifungal effects by damaging the plasma membranes of Candida albicans.
Lee DG; Kim PI; Park Y; Jang SH; Park SC; Woo ER; Hahm KS
J Pept Sci; 2002 Aug; 8(8):453-60. PubMed ID: 12212808
[TBL] [Abstract][Full Text] [Related]
6. Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.
Lee KH; Lee DG; Park Y; Kang DI; Shin SY; Hahm KS; Kim Y
Biochem J; 2006 Feb; 394(Pt 1):105-14. PubMed ID: 16255716
[TBL] [Abstract][Full Text] [Related]
7. Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans.
Lee DG; Park Y; Kim HN; Kim HK; Kim PI; Choi BH; Hahm KS
Biochem Biophys Res Commun; 2002 Mar; 291(4):1006-13. PubMed ID: 11866466
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.
Shin SY; Park EJ; Yang ST; Jung HJ; Eom SH; Song WK; Kim Y; Hahm KS; Kim JI
Biochem Biophys Res Commun; 2001 Jul; 285(4):1046-51. PubMed ID: 11467858
[TBL] [Abstract][Full Text] [Related]
9. HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane.
Park Y; Lee DG; Hahm KS
J Pept Sci; 2004 Apr; 10(4):204-9. PubMed ID: 15119592
[TBL] [Abstract][Full Text] [Related]
10. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1.
Lee DG; Kim HN; Park Y; Kim HK; Choi BH; Choi CH; Hahm KS
Biochim Biophys Acta; 2002 Jul; 1598(1-2):185-94. PubMed ID: 12147359
[TBL] [Abstract][Full Text] [Related]
11. Influence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1.
Crusca E; Rezende AA; Marchetto R; Mendes-Giannini MJ; Fontes W; Castro MS; Cilli EM
Biopolymers; 2011; 96(1):41-8. PubMed ID: 20560142
[TBL] [Abstract][Full Text] [Related]
12. A proline-hinge alters the characteristics of the amphipathic α-helical AMPs.
Lee JK; Gopal R; Park SC; Ko HS; Kim Y; Hahm KS; Park Y
PLoS One; 2013; 8(7):e67597. PubMed ID: 23935838
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones.
Park Y; Park SN; Park SC; Park JY; Park YH; Hahm JS; Hahm KS
Biochem Biophys Res Commun; 2004 Aug; 321(3):631-7. PubMed ID: 15358153
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.
Conlon JM; Abraham B; Galadari S; Knoop FC; Sonnevend A; Pál T
Peptides; 2005 Nov; 26(11):2104-10. PubMed ID: 15885852
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lethal murine candidiasis using HP (2-20), an antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1.
Ribeiro PD; Medina-Acosta E
Peptides; 2003 Nov; 24(11):1807-14. PubMed ID: 15019213
[TBL] [Abstract][Full Text] [Related]
16. Influence on the plasma membrane of Candida albicans by HP (2-9)-magainin 2 (1-12) hybrid peptide.
Lee DG; Park Y; Kim PI; Jeong HG; Woo ER; Hahm KS
Biochem Biophys Res Commun; 2002 Oct; 297(4):885-9. PubMed ID: 12359236
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.
Park CB; Yi KS; Matsuzaki K; Kim MS; Kim SC
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8245-50. PubMed ID: 10890923
[TBL] [Abstract][Full Text] [Related]
18. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid.
Lee DG; Kim PI; Park Y; Woo ER; Choi JS; Choi CH; Hahm KS
Biochem Biophys Res Commun; 2002 Apr; 293(1):231-8. PubMed ID: 12054589
[TBL] [Abstract][Full Text] [Related]
19. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
20. The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity.
Cuervo JH; Rodriguez B; Houghten RA
Pept Res; 1988; 1(2):81-6. PubMed ID: 2980783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
